Tandem Diabetes Care, Inc. (TNDM)
22.71
-0.83
(-3.53%)
USD |
NASDAQ |
Jan 07, 16:00
22.71
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Research and Development Expense (Quarterly): 47.88M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insulet Corp. | 77.20M |
| Intuitive Surgical, Inc. | 329.40M |
| Integra LifeSciences Holdings Corp. | 20.42M |
| Merit Medical Systems, Inc. | 23.97M |
| iRhythm Technologies, Inc. | 21.03M |